CORRESP Filing
Silo Pharma, Inc.
Date: April 30, 2025 · CIK: 0001514183 · Accession: 0001213900-25-037247
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286777
Letter
Re: Silo Pharma, Inc.
April 30, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Attention: Jessica Dickerson
Form S-1 Registration Statement
Filed April 25, 2025 File No. 333-286777
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on April 28, 2025, in which we requested for acceleration of the effective date of the above-referenced registration statement to 12:00 p.m., Eastern Time, on Wednesday, April 30, 2025, or as soon thereafter as practicable. At this time, we are no longer requesting that such registration statement be declared effective and we hereby formally withdraw our request for acceleration of the effective date thereof.
Very Truly Yours,
SILO PHARMA, INC.
Show Raw Text
CORRESP 1 filename1.htm April 30, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Jessica Dickerson Re: Silo Pharma, Inc. Form S-1 Registration Statement Filed April 25, 2025 File No. 333-286777 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on April 28, 2025, in which we requested for acceleration of the effective date of the above-referenced registration statement to 12:00 p.m., Eastern Time, on Wednesday, April 30, 2025, or as soon thereafter as practicable. At this time, we are no longer requesting that such registration statement be declared effective and we hereby formally withdraw our request for acceleration of the effective date thereof. Very Truly Yours, SILO PHARMA, INC. By: /s/ Eric Weisblum Name: Eric Weisblum Title: Chief Executive Officer